74 related articles for article (PubMed ID: 29916918)
41. [
Costes J; Casasagrande K; Dubegny C; Castillo J; Kaufman J; Masset J; Vriamont C; Warnier C; Faivre-Chauvet A; Delage JA
J Labelled Comp Radiopharm; 2023 Oct; 66(12):400-410. PubMed ID: 37679888
[TBL] [Abstract][Full Text] [Related]
42. Role of [68Ga]-pentixafor positron emission tomography/computed tomography imaging in assessing disease activity in patients with lupus nephritis: A pilot study.
Nair A; Pandit N; Kavadichanda C
Lupus; 2023 Oct; 32(11):1267-1275. PubMed ID: 37691452
[TBL] [Abstract][Full Text] [Related]
43. Brain Nocardiosis Mimicking Intracerebral Invasion on 68Ga-Pentixafor PET/CT in a Patient With Multiple Myeloma.
Zhao X; Dai M; Li N; Zhang J; Zhao X
Clin Nucl Med; 2024 Jun; ():. PubMed ID: 38914120
[TBL] [Abstract][Full Text] [Related]
44. Pentixather: paving the way for radioligand therapy in oncohematology.
Bauckneht M; Filippi L
Expert Rev Anticancer Ther; 2024 May; 24(5):205-209. PubMed ID: 38593347
[No Abstract] [Full Text] [Related]
45. Chemokine receptor-4 targeted PET/CT with
Pan Q; Cao X; Luo Y; Li J; Feng J; Li F
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):537-546. PubMed ID: 31776631
[TBL] [Abstract][Full Text] [Related]
46. CXCR4 PET/MRI for follow-up of gastric mucosa-associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication.
Mayerhoefer ME; Raderer M; Lamm W; Weber M; Kiesewetter B; Rohrbeck J; Simonitsch-Klupp I; Hacker M; Leisser A; Nics L; Schmitl S; Wester HJ; Haug A
Blood; 2022 Jan; 139(2):240-244. PubMed ID: 34525196
[TBL] [Abstract][Full Text] [Related]
47. CXCR4 PET imaging of mantle cell lymphoma using [
Mayerhoefer ME; Raderer M; Lamm W; Pichler V; Pfaff S; Weber M; Kiesewetter B; Hacker M; Kazianka L; Staber PB; Wester HJ; Rohrbeck J; Simonitsch-Klupp I; Haug A
Theranostics; 2021; 11(2):567-578. PubMed ID: 33391493
[TBL] [Abstract][Full Text] [Related]
48. Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [
Pan Q; Luo Y; Zhang Y; Chang L; Li J; Cao X; Li J; Li F
EJNMMI Res; 2020 Aug; 10(1):89. PubMed ID: 32757068
[TBL] [Abstract][Full Text] [Related]
49. Advances in PET Imaging of the CXCR4 Receptor: [
Lindenberg L; Ahlman M; Lin F; Mena E; Choyke P
Semin Nucl Med; 2024 Jan; 54(1):163-170. PubMed ID: 37923671
[TBL] [Abstract][Full Text] [Related]
50. Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4 for Imaging and Therapy in Related Disease.
Chen Z; Xue Q; Yao S
Mini Rev Med Chem; 2023; 23(7):787-803. PubMed ID: 36529918
[TBL] [Abstract][Full Text] [Related]
51. Imaging of Chemokine Receptor CXCR4 in Mycosis Fungoides Using 68Ga-Pentixafor PET/CT.
Kuyumcu S; Yilmaz E; Büyükkaya F; Özkan ZG; Ünal SN
Clin Nucl Med; 2018 Aug; 43(8):606-608. PubMed ID: 29916918
[TBL] [Abstract][Full Text] [Related]
52.
Luo Y; Cao X; Pan Q; Li J; Feng J; Li F
J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745
[No Abstract] [Full Text] [Related]
53. Imaging Inflammation in Atherosclerosis with CXCR4-Directed
Kircher M; Tran-Gia J; Kemmer L; Zhang X; Schirbel A; Werner RA; Buck AK; Wester HJ; Hacker M; Lapa C; Li X
J Nucl Med; 2020 May; 61(5):751-756. PubMed ID: 31653710
[TBL] [Abstract][Full Text] [Related]
54. Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia.
Luo Y; Pan Q; Feng J; Cao X; Li F
Clin Nucl Med; 2018 Jul; 43(7):548-550. PubMed ID: 29742593
[TBL] [Abstract][Full Text] [Related]
55. [
Lapa C; Schreder M; Schirbel A; Samnick S; Kortüm KM; Herrmann K; Kropf S; Einsele H; Buck AK; Wester HJ; Knop S; Lückerath K
Theranostics; 2017; 7(1):205-212. PubMed ID: 28042328
[TBL] [Abstract][Full Text] [Related]
56. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
Bluemel C; Hahner S; Heinze B; Fassnacht M; Kroiss M; Bley TA; Wester HJ; Kropf S; Lapa C; Schirbel A; Buck AK; Herrmann K
Clin Nucl Med; 2017 Jan; 42(1):e29-e34. PubMed ID: 27819856
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
